$17.79
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Kailera weight loss pill trial results: Nausea sinks stock
Update: Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial; Shares Fall
Overview
52-week range
$19
$28
0% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
+1.9%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 26, 2026 | Mar/2026 | $3650.00 | — | — | — | +1.9% | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-17983.00 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | — | — | — |
| Cost of revenue | — | — | — |
| Gross profit | — | — | — |
| Operating income | $-85M | — | $-20M |
| Net income | $-79M | — | $-18M |
| EPS (diluted) | $-3650.00 | — | $-17983.00 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Mar 2025 |
|---|---|---|---|
| Cash & equivalents | $112M | $160M | $102M |
| Inventory | — | — | — |
| Total current assets | $530M | $558M | — |
| Total assets | $625M | $692M | — |
| Long-term debt | — | — | — |
| Total liabilities | $64M | $56M | — |
| Total equity | $-432M | $-356M | $-235M |
Implied volatility — last 90 days
No IV snapshots yet for KLRA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.